Ovid Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OVID and other ETFs, options, and stocks.

About OVID

Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During on April 1, 2014 and is headquartered in New York, NY. 

CEO
Margaret Alexander
CEOMargaret Alexander
Employees
23
Employees23
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2014
Founded2014
Employees
23
Employees23

OVID Key Statistics

Market cap
203.74M
Market cap203.74M
Price-Earnings ratio
-3.05
Price-Earnings ratio-3.05
Dividend yield
Dividend yield
Average volume
1.86M
Average volume1.86M
High today
$1.60
High today$1.60
Low today
$1.50
Low today$1.50
Open price
$1.55
Open price$1.55
Volume
1.49M
Volume1.49M
52 Week high
$2.01
52 Week high$2.01
52 Week low
$0.2425
52 Week low$0.2425

Stock Snapshot

The current Ovid Therapeutics(OVID) stock price is $1.59, with a market capitalization of 203.74M. The stock trades at a price-to-earnings (P/E) ratio of -3.05.

During the trading session on 2026-02-02, Ovid Therapeutics(OVID) shares reached a daily high of $1.60 and a low of $1.50. At a current price of $1.59, the stock is +6.0% higher than the low and still -0.6% under the high.

Trading activity shows a volume of 1.49M, compared to an average daily volume of 1.86M.

Over the past 52 weeks, Ovid Therapeutics(OVID) stock has traded between a high of $2.01 and a low of $0.24.

Over the past 52 weeks, Ovid Therapeutics(OVID) stock has traded between a high of $2.01 and a low of $0.24.

OVID News

Simply Wall St 3d
Both retail investors who control a good portion of Ovid Therapeutics Inc. along with institutions must be dismayed after last week's 11% decrease

Advertisement Key Insights Significant control over Ovid Therapeutics by retail investors implies that the general public has more power to influence manageme...

Both retail investors who control a good portion of Ovid Therapeutics Inc. along with institutions must be dismayed after last week's 11% decrease

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own OVID. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.